Speciality: Nephrology
Description:
Welcome to our podcast. Today, we’re discussing the early signs of kidney disease, a condition that often goes unnoticed until it’s advanced. The kidneys filter waste from our blood, but when they’re struggling, you might notice subtle symptoms. These include persistent fatigue, swelling in your ankles or face, changes in urination such as foamy urine or going more often at night, and unexplained itching. High blood pressure can also be both a cause and a symptom. If you experience any of these signs, it’s important to consult your doctor promptly. Early detection can make a significant difference in managing kidney disease and protecting your long-term health. Stay informed and take care of your kidneys.
See More Webinars @ Hidoc Webinars
1.
Microplastics can cause malignant changes in lung cells
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer
1.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
2.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
3.
Innovative Approaches in Oncology for Modern Medicine
4.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
5.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Screening in Cancer Prevention
2.
From Guidelines to Practice: Hematology
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation